<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2594-2166</journal-id>
<journal-title><![CDATA[Medicina y ética]]></journal-title>
<abbrev-journal-title><![CDATA[Med. ética]]></abbrev-journal-title>
<issn>2594-2166</issn>
<publisher>
<publisher-name><![CDATA[Universidad Anáhuac México, Facultad de Bioética]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2594-21662021000200341</article-id>
<article-id pub-id-type="doi">10.36105/mye.2021v32n2.01</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Principios y regulaciones que orientan la evaluación de ensayos clínicos patrocinados por la industria farmacéutica en Comités de Ética de Investigación en Panamá]]></article-title>
<article-title xml:lang="en"><![CDATA[Principles and regulations for the evaluation of clinical research funded by the pharmaceutical industry in Ethics Research Committees in Panama]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vergès]]></surname>
<given-names><![CDATA[Claude]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Farinoni]]></surname>
<given-names><![CDATA[Noemí]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[Matilde]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Interamericana de Educación a Distancia de Panamá  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Panamá Facultad de Humanidades Centro Investigaciones]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Panamá</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Panamá  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Panamá</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<volume>32</volume>
<numero>2</numero>
<fpage>341</fpage>
<lpage>405</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2594-21662021000200341&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2594-21662021000200341&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2594-21662021000200341&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen Se presentan los resultados de una investigación multicéntrica de evaluación de los Comités de Ética de Investigación (CEI) en Panamá, la cual busca mecanismos que ayuden a fortalecer su capacidad para evaluar, desde un enfoque de bioética y derechos humanos, los protocolos de los ensayos clínicos financiados por la industria farmacéutica o por los centros extranjeros de investigación, así como monitorear la implementación de los protocolos aprobados. Se revisó documentación suficiente y se hicieron entrevistas a miembros de cuatro CEI. A partir de ahí, se concluye que en Panamá los CEI respetan las normas internacionales de funcionamiento y de revisión de protocolos, y que los problemas encontrados guardan relación con su experiencia, el contexto social y la evolución de los intereses de las compañías farmacéuticas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract The results of a multicenter research evaluation of the Research Ethics Committees (CEI) in Panama are presented, which seeks mechanisms that help strengthen their capacity to evaluate, from a bioethics and human rights approach, the protocols of the trials clinics financed by the pharmaceutical industry or foreign research centers, as well as monitoring the implementation of approved protocols. Sufficient documentation was reviewed and interviews were conducted with members of four CIS. From there, it is concluded that in Panama the CIS respect the international standards of operation and protocol review, and that the problems encountered are related to their experience, the social context and the evolution of the interests of pharmaceutical companies.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Comité de Bioética de Investigación]]></kwd>
<kwd lng="es"><![CDATA[ensayos clínicos financiados]]></kwd>
<kwd lng="es"><![CDATA[investigaciones clínicas]]></kwd>
<kwd lng="en"><![CDATA[Bioethics Research Committees]]></kwd>
<kwd lng="en"><![CDATA[financed clinical protocols]]></kwd>
<kwd lng="en"><![CDATA[clinical trials]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="">
<collab>Universidad El Bosque, Departamento de Bioética</collab>
<source><![CDATA[La situación de los Comités de Ética de Investigación en América Latina y El Caribe]]></source>
<year>2016</year>
<page-range>29-32</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<collab>National Institutes of Health</collab>
<article-title xml:lang=""><![CDATA[Aprenda más sobre la investigación clínica de los NIH]]></article-title>
<source><![CDATA[Investigación clínica]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lolas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Quezada]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Investigación en Salud]]></article-title>
<source><![CDATA[Dimensión Ética]]></source>
<year>2006</year>
<edition>Primera</edition>
<publisher-name><![CDATA[CIEB, Universidad de Chile]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Panama, its politics, and the canal against itself]]></article-title>
<source><![CDATA[Oxford Research Encyclopedia of Politics]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vergès]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chapter 15, the history of bioethics in Panama]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Pessini]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ibero-American Bioethics: History and Perspectives]]></source>
<year>2010</year>
<page-range>175-92</page-range><publisher-name><![CDATA[Springer Science + Business Media]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Guías operacionales para comités de ética que evalúan investigación biomédica]]></source>
<year>2000</year>
<page-range>1</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="">
<collab>Hospital del Niño, Dr. José Renán Esquivel</collab>
<source><![CDATA[Reglamento del CBI]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="">
<source><![CDATA[Instituto Conmemorativo Gorgas de Estudios en Salud, CBI]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="">
<source><![CDATA[Comité Nacional de Bioética de Investigación]]></source>
<year></year>
<publisher-loc><![CDATA[Panamá ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Comité de Bioética]]></article-title>
<source><![CDATA[Pacífica Salud]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="book">
<collab>UNESCO</collab>
<source><![CDATA[Guía Nº 1. Creación de Comités de Bioética]]></source>
<year>2005</year>
<publisher-name><![CDATA[UNESDOC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="book">
<collab>UNESCO</collab>
<source><![CDATA[Guía Nº 2. Funcionamiento de los comités de bioética: procedimientos y políticas]]></source>
<year>2006</year>
<publisher-name><![CDATA[UNESDOC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fuentes]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Revilla]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acreditación de Comités de Ética en Investigación, como parte de un proceso]]></article-title>
<source><![CDATA[An Fac Med]]></source>
<year>2007</year>
<volume>68</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>67-74</page-range><publisher-loc><![CDATA[Lima ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="journal">
<collab>Ministerio de Salud</collab>
<article-title xml:lang=""><![CDATA[Ley 84 del 14 de mayo de 2019: Que promueve la investigación para la salud y establece su rectoría y gobernanza, y dicta otras disposiciones]]></article-title>
<source><![CDATA[Gaceta Oficial Digital]]></source>
<year>2019</year>
<numero>28775-A</numero>
<issue>28775-A</issue>
</nlm-citation>
</ref>
<ref id="B15">
<label>15.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Minaya]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Fuentes-Delgado]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ugalde]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Homedes]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A missing piece in clinical trial inspections in Latin America: Interviews with research subjects in Peru]]></article-title>
<source><![CDATA[J Empir Res Hum Res Ethics]]></source>
<year>2017</year>
<volume>12</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>232-45</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16.</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ensayos clínicos, claves para desarrollar nuevos fármacos y valiosos para la economía y el ahorro de costes sanitarios]]></article-title>
<source><![CDATA[Noticias]]></source>
<year>2019</year>
<publisher-loc><![CDATA[España ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B17">
<label>17.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Angel]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transparency hasn&#8217;t stopped drug companies from corrupting medical research]]></article-title>
<source><![CDATA[New York Times]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B18">
<label>18.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lorenzo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Garrafa]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ensayos clínicos, Estado y sociedad: ¿dónde termina la ciencia y empieza el negocio?]]></article-title>
<source><![CDATA[Salud Colectiva]]></source>
<year>2011</year>
<volume>7</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>166-70</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bachelet]]></surname>
<given-names><![CDATA[VC]]></given-names>
</name>
<name>
<surname><![CDATA[Pardo-Hernández]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calidad del reporte y riesgo de sesgo delos ensayos clínicos aleatorizados]]></article-title>
<source><![CDATA[Medwave]]></source>
<year>2019</year>
<volume>19</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B20">
<label>20.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abbott]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Grady]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systematic review of the empirical literature evaluating IRBs: What we know and what we still need to learn]]></article-title>
<source><![CDATA[J. Empir. Res. Hum. Res. Ética]]></source>
<year>2011</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-19</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodwin]]></surname>
<given-names><![CDATA[MA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Institutional corruption and the pharmaceutical policy introduction]]></article-title>
<source><![CDATA[J Law Med Ethics]]></source>
<year>2013</year>
<volume>41</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>544-52</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weissman]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Koski]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Vogeli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Thiessen]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[EG.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Opinions of IRB Members and chairs regarding investigators&#8217; relationships with industry]]></article-title>
<source><![CDATA[J Empir Res Hum Res Ethics]]></source>
<year>2008</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-13</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reuben]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Milliken]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
<name>
<surname><![CDATA[Paradis]]></surname>
<given-names><![CDATA[LJ.]]></given-names>
</name>
</person-group>
<source><![CDATA[The future of cancer research: Accelerating scientific innovation. President&#8217;s cancer panel Annual Report 2010-2011]]></source>
<year>2012</year>
<publisher-name><![CDATA[National Institutes of Health National Cancer Institute]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24.</label><nlm-citation citation-type="">
<collab>Redacción Médica</collab>
<source><![CDATA[Sesgo en protocolos de investigación oncológica]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B25">
<label>25.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rudra]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lenk]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Process of risk assessment by research ethics committees: foundations, shortcomings and open questions]]></article-title>
<source><![CDATA[J Med Ethics]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B26">
<label>26.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klitzman]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Views and Experiences of IRBS concerning research integrity]]></article-title>
<source><![CDATA[J Law Med Ethics]]></source>
<year>2011</year>
<volume>39</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>513-28</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ong]]></surname>
<given-names><![CDATA[YT]]></given-names>
</name>
<name>
<surname><![CDATA[Yoon]]></surname>
<given-names><![CDATA[NYS]]></given-names>
</name>
<name>
<surname><![CDATA[Yap]]></surname>
<given-names><![CDATA[HW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Training clinical ethics committee members between 1992 and 2017: Systematic scoping review]]></article-title>
<source><![CDATA[J Med Ethics]]></source>
<year>2020</year>
<volume>46</volume>
<page-range>36-42</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaplan]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[In clinical trials, for-profit review boards are taking over for hospitals. Should they?]]></article-title>
<source><![CDATA[STAT]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B29">
<label>29.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Molina]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Arroba]]></surname>
<given-names><![CDATA[BML.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nueva regulación de ensayos clínicos con medicamentos en España]]></article-title>
<source><![CDATA[Pediatría de Atención Primaria]]></source>
<year>2016</year>
<volume>18</volume>
<page-range>e229-37</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
